News results: "Roche"

« 30 results in "Health"« 2 results in "Science"« 5 results in "Specials"
« 1 results in "Business"« 1 results in "World"
dotclear

Health

Avastin Raises Risk of Blood Clots

An analysis of 15 clinical trials involving Genentech’s cancer drug Avastin has found that the...
» read full story November 20th, 2008 - 16:37
Avastin Drug Linked to Blood Clots

Avastin Drug Linked to Blood Clots

Research conducted by United States scientists has revealed that the Avastin cancer drug...
» read full story November 19th, 2008 - 19:56
Avastin Linked to Blood Clot Risk, New Analysis Finds

Avastin Linked to Blood Clot Risk, New Analysis Finds

Genentech’s cancer drug Avastin was linked to a significantly increased risk of blood clots in the...
» read full story November 19th, 2008 - 14:10
Lung Cancer Treatment Drug Tarceva Makes the Disease Possible To Treat

Lung Cancer Treatment Drug Tarceva Makes the Disease Possible To Treat

The drug Tarceva, made by OSI Pharmaceuticals has been found to cause an increase in survival rates...
» read full story November 08th, 2008 - 23:55
Tarceva Slows Progress Of Lung Cancer, Study Shows

Tarceva Slows Progress Of Lung Cancer, Study Shows

After a study disclosed that the drug Tarceva was efficient in prolonging lung cancer survival when...
» read full story November 08th, 2008 - 14:33
OSI Shares Gain, Despite Preliminary Results, Tarceva Meets Its Goal

OSI Shares Gain, Despite Preliminary Results, Tarceva Meets Its Goal

Shares of OSI Pharmaceutical rose $5.25, or 15 percent, to $40.65 at 4 p.m. New York time in Nasdaq...
» read full story November 08th, 2008 - 14:30

Genentech’s Avastin reaches Phase 3

Genentech has recently announced that the study of Avastin will continue as planned, reaching phase...
» read full story October 20th, 2008 - 22:42
Tarceva-Avastin Combination Doesn’t Prolong Lung Cancer Survival

Tarceva-Avastin Combination Doesn’t Prolong Lung Cancer Survival

According to the results of a late-stage clinical trial into the benefits of combining Genentech’s...
» read full story October 07th, 2008 - 14:00
ProStrakan’s Anti-Nausea Patch Gets FDA Clearance

ProStrakan’s Anti-Nausea Patch Gets FDA Clearance

Patients undergoing chemotherapy will soon be able to use a medication patch to ease the nausea...
» read full story September 16th, 2008 - 14:45
Update: Pfizer Is Seeking FDA’s Approval For Osteoporosis Drug

Update: Pfizer Is Seeking FDA’s Approval For Osteoporosis Drug

Pfizer, the world’s biggest drugmaker, is seeking U.S. Food and Drug Administration approval for...
» read full story September 09th, 2008 - 14:30
Pfizer’s Osteoporosis Treatment Under FDA Analysis

Pfizer’s Osteoporosis Treatment Under FDA Analysis

Today, Pfizer Incorporated appeared for the third time before Federal Drug Administration medical...
» read full story September 08th, 2008 - 23:12
Contaminated “Roller Sandwiches” Recalled from Roche Bros.’ Shelves

Contaminated “Roller Sandwiches” Recalled from Roche Bros.’ Shelves

The season of mosquito and salmonella outbreaks continues with other food-born outbreaks. The...
» read full story August 07th, 2008 - 14:30
FDA Panel Backs New Drug for Moderate or Severe Rheumatoid Arthritis

FDA Panel Backs New Drug for Moderate or Severe Rheumatoid Arthritis

By a 10-1 vote, a government advisory panel Tuesday backed Roche Holding AG's (RHHBY) drug Actemra...
» read full story July 30th, 2008 - 19:10
Antiretroviral Therapy Adds 13 Years More for HIV Patients

Antiretroviral Therapy Adds 13 Years More for HIV Patients

New research published in this week’s special HIV/AIDS issue of The Lancet reveals that the life...
» read full story July 25th, 2008 - 12:00
Tamiflu Maker Tries to Convince Companies to Stockpile Drug

Tamiflu Maker Tries to Convince Companies to Stockpile Drug

Roche is apparently discontent that sales of its Tamiflu influenza drug have dropped and seeks new...
» read full story June 27th, 2008 - 20:49
The Fighters Against Cancer Have Roche As A New Ally

The Fighters Against Cancer Have Roche As A New Ally

The reports about the Swiss pharmaceutical giant Roche AG planning to invest in the development of...
» read full story June 18th, 2008 - 16:51
New Data Triggers Revision of Erbitrux vs. Avastin Study

New Data Triggers Revision of Erbitrux vs. Avastin Study

While the European Medicines Agency, based in London, has approved the use of Erbitux, produced by...
» read full story June 04th, 2008 - 22:37
Erbitux Boosts Survival in Lung Cancer Patients

Erbitux Boosts Survival in Lung Cancer Patients

Results of a long awaited clinical trial of ImClone Systems Inc's Erbitux, called Flex, give hopes...
» read full story June 01st, 2008 - 08:50

Zometa Reduces Cancer Recurrence

Zoledronate, marketed by Novartis under the trade name Zometa, has been found to significantly...
» read full story May 31st, 2008 - 22:10
EU Backs Merck KGaA’s Erbitux for First-Line Use

EU Backs Merck KGaA’s Erbitux for First-Line Use

Germany’s Merck KGaA announced Friday that Erbitux, which it licensed from ImClone System Inc and...
» read full story May 31st, 2008 - 08:20
Herceptin Combined with Chemo Halts Progress of Breast Cancer

Herceptin Combined with Chemo Halts Progress of Breast Cancer

Swiss drugmaker Roche Holding AG announced Friday that new data from a study with Herceptin showed...
» read full story May 30th, 2008 - 12:35
FDA Warns Over Two Drugs’ Birth Defects Risks

FDA Warns Over Two Drugs’ Birth Defects Risks

The FDA issued a new alert on Friday, warning the doctors about the risk of first-trimester...
» read full story May 17th, 2008 - 18:40
Study: Glaxo’s Tykerb Reduces Breast Cancer-Causing Stem Cells

Study: Glaxo’s Tykerb Reduces Breast Cancer-Causing Stem Cells

GlaxoSmithKline Plc. said a new study into breast cancer-causing stem cells showed its cancer drug...
» read full story April 17th, 2008 - 16:17
FDA Reviews Two Transplant Drugs over Rare Disorder Risk

FDA Reviews Two Transplant Drugs over Rare Disorder Risk

The U.S. Food and Drug Administration announced it is reviewing data involving a link between two...
» read full story April 14th, 2008 - 16:53
Roche’s Breast Cancer Drug Herceptin Gets Clearance in Japan

Roche’s Breast Cancer Drug Herceptin Gets Clearance in Japan

Japan’s health authorities have approved Roche’s cancer drug Herceptin for treatment...
» read full story February 29th, 2008 - 16:50
CDC Panel: All Children up to Age 18 Should Get Flu Shots

CDC Panel: All Children up to Age 18 Should Get Flu Shots

A panel of federal vaccine advisers recommended Wednesday that all children aged from six months...
» read full story February 28th, 2008 - 11:18
Avastin’s Approval Leads to Jump in Shares for Roche

Avastin’s Approval Leads to Jump in Shares for Roche

The forecasts for Roche Holding AG saw quite a spike on Monday following the announcement that the...
» read full story February 25th, 2008 - 14:39
US Health Officials Held Urgent Meeting over Next Year’s Vaccine

US Health Officials Held Urgent Meeting over Next Year’s Vaccine

The number of states affected by influenza in the U.S. has risen from 44 at the middle of this...
» read full story February 23rd, 2008 - 18:30
Avastin Approved for Breast Cancer

Avastin Approved for Breast Cancer

The Food and Drug Administration announced in December that Genentech Inc.'s drug Avastin failed to...
» read full story February 22nd, 2008 - 23:21
Tamiflu Resistant Flu Virus Strikes European Countries

Tamiflu Resistant Flu Virus Strikes European Countries

A small but significant number of flu viruses resistant to Tamiflu have been detected in more than...
» read full story February 01st, 2008 - 11:11
dotclear

Science

Avastin Drug Linked To Blood Clots

Avastin Drug Linked To Blood Clots

Research conducted by United States scientists has revealed that the Avastin cancer drug...
» read full story November 20th, 2008 - 11:00
Penn State Scientists Untangle Woolly Mammoth Genetic Code

Penn State Scientists Untangle Woolly Mammoth Genetic Code

Penn State University scientists are to first to untangle the genetic code of an extinct animal,...
» read full story November 20th, 2008 - 08:16
dotclear

Specials

Study: Lung Cancer Drug Tarceva Slows Progression of the Disease

Study: Lung Cancer Drug Tarceva Slows Progression of the Disease

Lung cancer drug Tarceva jointly developed by OSI Pharmaceuticals Inc., Genentech Inc. and Roche...
» read full story November 10th, 2008 - 15:08
FDA Panel Recommends New Arthritis Drug Approval

FDA Panel Recommends New Arthritis Drug Approval

An FDA panel voted Tuesday 10 to 1 for the approval of a new drug that fights against rheumatoid...
» read full story July 30th, 2008 - 20:09
Yves Saint Laurent Is Tearfully Laid to Rest

Yves Saint Laurent Is Tearfully Laid to Rest

A grand and emotional funeral ceremony took place Thursday, May 5, at the Saint Roche church in...
» read full story June 06th, 2008 - 10:32
One Last Goodbye to Yves Saint Laurent

One Last Goodbye to Yves Saint Laurent

Although one of the most influential designers of the 20th century left this world, which...
» read full story June 05th, 2008 - 21:29
FDA: Transplant Drugs CellCept and Myfortic Carry Fetal Risks

FDA: Transplant Drugs CellCept and Myfortic Carry Fetal Risks

The U.S. Food and Drug Administration released a statement on Friday warning that certain...
» read full story May 19th, 2008 - 11:29
dotclear

Business

OSI Shares Gain After Study Shows Tarceva Meets Its Goal

OSI Shares Gain After Study Shows Tarceva Meets Its Goal

Shares of OSI Pharmaceutical rose $5.25, or 15 percent, to $40.65 at 4 p.m. New York time in Nasdaq...
» read full story November 10th, 2008 - 06:58
dotclear

World

EU Backs Erbitux as First Line Drug Against Cancer

EU Backs Erbitux as First Line Drug Against Cancer

The European Medicines Agency, based in London, has approved the use of Erbitux, produced by Merck...
» read full story June 02nd, 2008 - 11:07
dotclear
dotclear
dotclear
Photos Gallery
dotclear